文献速递系统性红斑狼疮

联合I型干扰素与中性粒细胞基因评分识别高活动性系统性红斑狼疮

Identification of highly active systemic lupus erythematosus by combined type I interferon and neutrophil gene scores vs classical serologic markers.
PubMed 文献 · Rheumatology (Oxford) · 2020-01-01

该研究在140例SLE患者中评估I型干扰素(IFN-I)、多形核中性粒细胞(PMN)和浆母细胞(PB)基因表达特征与临床表型的关系。结果显示IFN-I和PMN基因评分与不同SLE临床特征相关,二者联合与高疾病活动度显著相关,且优于抗dsDNA、抗C1q抗体和补体水平预测SLE活动度。

要点

  • IFN-I基因评分与皮肤受累及关节炎相关,MX1蛋白水平与IFN-I评分相关并呈现相似临床表型。
  • PMN基因评分与SLE发热、浆膜炎、白细胞减少和糖皮质激素使用相关。
  • 联合IFN-I和PMN基因评分与高疾病活动度显著相关,预测SLE活动度优于经典血清学标志物。

核心结论

  • IFN-I和PMN基因评分区分不同的SLE临床特征,二者联合可识别高疾病活动度。
  • MX1蛋白水平与IFN-I基因表达表现相似。

研究设计与样本

  • 研究纳入140例特征明确、多学科管理的SLE患者,采集全血、血清和临床数据。
  • 采用NanoString技术检测基因表达,使用37个探针计算6个IFN-I评分、1个PMN评分和1个PB评分;蛋白水平用ELISA测定。

主要发现

  • 根据评分不同,45-50%的SLE患者显示高IFN-I基因表达。
  • 全部6个IFN-I评分均与活动性皮肤受累显著相关,其中2个与关节炎相关。
  • IFN诱导的Mx1蛋白(MX1)水平与IFN-I评分相关(P < 0.0001),并与相似的临床表型相关。
  • 25%的SLE患者显示高PMN基因表达,与SLE发热、浆膜炎、白细胞减少和糖皮质激素使用相关。
  • PB基因表达受免疫抑制剂显著影响,与SLE特征无关联。

关键数值与推荐

  • 联合IFN-I和PMN基因评分与高疾病活动度显著相关,在预测SLE活动度方面优于抗dsDNA抗体、抗C1q抗体和补体水平。

临床怎么用

  • 联合IFN-I和PMN基因评分可能有助于识别高疾病活动度的SLE患者。
  • MX1蛋白水平或可作为IFN-I基因表达的替代指标。

局限性

  • PB基因表达受免疫抑制剂影响,未显示与SLE特征关联。
  • 研究未报告联合评分预测活动度的具体阈值或效应量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: In SLE, heterogeneous clinical expression and activity may reflect diverse pathogenic and/or effector mechanisms. We investigated SLE heterogeneity by assessing the expression of three gene sets representative of type I IFN (IFN-I), polymorphonuclear neutrophil (PMN) and plasmablast (PB) signatures in a well-characterized, multidisciplinary cohort of SLE patients. We further assessed whether individual gene products could be representative of these three signatures. METHODS: Whole blood, serum and clinical data were obtained from 140 SLE individuals. Gene expression was assessed by NanoString technology, using a panel of 37 probes to compute six IFN-I, one PMN and one PB scores. Protein levels were measured by ELISA. RESULTS: Depending on the score, 45-50% of SLE individuals showed high IFN-I gene expression. All six IFN-I scores were significantly associated with active skin involvement, and two of six were associated with arthritis. IFN-induced Mx1 protein (MX1) level was correlated with IFN-I score (P < 0.0001) and associated with a similar clinical phenotype. In all, 25% of SLE individuals showed high PMN gene expression, associated with SLE fever, serositis, leukopoenia and glucocorticoid use. PB gene expression was highly affected by immunosuppressant agents, with no association with SLE features. Combined IFN-I and PMN gene scores were significantly associated with high disease activity and outperformed anti-dsDNA and anti-C1q autoantibody and complement levels for predicting SLE activity. CONCLUSION: IFN-I and PMN gene scores segregate with distinct SLE clinical features, and their combination may identify high disease activity. MX1 protein level performed similar to IFN-I gene expression.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Chasset F, Ribi C, Trendelenburg M, et al. Identification of highly active systemic lupus erythematosus by combined type I interferon and neutrophil gene scores vs classical serologic markers. Rheumatology (Oxford). 2020. PMID: 32375176. doi:10.1093/rheumatology/keaa167

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。